In addition to prolonged proliferation and higher cell yield, NKp30-CD28 CAR TCRKO T cells elicited superior IFN-γ release upon recognition of B7H6 expressed on leukemia and melanoma cell lines and primary AML blasts. The gene discussed is CD28; the disease is melanoma.